225 related articles for article (PubMed ID: 26735910)
21. New Tetrahydroacridine Hybrids with Dichlorobenzoic Acid Moiety Demonstrating Multifunctional Potential for the Treatment of Alzheimer's Disease.
Czarnecka K; Girek M; Wójtowicz P; Kręcisz P; Skibiński R; Jończyk J; Łątka K; Bajda M; Walczak A; Galita G; Kabziński J; Majsterek I; Szymczyk P; Szymański P
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466601
[TBL] [Abstract][Full Text] [Related]
22. Design and synthesis of novel anti-Alzheimer's agents: Acridine-chromenone and quinoline-chromenone hybrids.
Najafi Z; Saeedi M; Mahdavi M; Sabourian R; Khanavi M; Tehrani MB; Moghadam FH; Edraki N; Karimpor-Razkenari E; Sharifzadeh M; Foroumadi A; Shafiee A; Akbarzadeh T
Bioorg Chem; 2016 Aug; 67():84-94. PubMed ID: 27289559
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and biological evaluation of new phthalimide and saccharin derivatives with alicyclic amines targeting cholinesterases, beta-secretase and amyloid beta aggregation.
Panek D; Więckowska A; Wichur T; Bajda M; Godyń J; Jończyk J; Mika K; Janockova J; Soukup O; Knez D; Korabecny J; Gobec S; Malawska B
Eur J Med Chem; 2017 Jan; 125():676-695. PubMed ID: 27721153
[TBL] [Abstract][Full Text] [Related]
24. 6-Methyluracil Derivatives as Bifunctional Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease.
Semenov VE; Zueva IV; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
ChemMedChem; 2015 Nov; 10(11):1863-74. PubMed ID: 26412714
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.
Xie SS; Wang XB; Li JY; Yang L; Kong LY
Eur J Med Chem; 2013 Jun; 64():540-53. PubMed ID: 23685572
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, characterization, and molecular docking analysis of novel benzimidazole derivatives as cholinesterase inhibitors.
Yoon YK; Ali MA; Wei AC; Choon TS; Khaw KY; Murugaiyah V; Osman H; Masand VH
Bioorg Chem; 2013 Aug; 49():33-9. PubMed ID: 23886696
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.
Bautista-Aguilera OM; Esteban G; Bolea I; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Samadi A; Soriano E; Unzeta M; Marco-Contelles J
Eur J Med Chem; 2014 Mar; 75():82-95. PubMed ID: 24530494
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of 7H-thiazolo[3,2-b]-1,2,4-triazin-7-one derivatives as dual binding site acetylcholinesterase inhibitors.
Liu S; Shang R; Shi L; Wan DC; Lin H
Eur J Med Chem; 2014 Jun; 81():237-44. PubMed ID: 24844448
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents.
Luo W; Su YB; Hong C; Tian RG; Su LP; Wang YQ; Li Y; Yue JJ; Wang CJ
Bioorg Med Chem; 2013 Dec; 21(23):7275-82. PubMed ID: 24148835
[TBL] [Abstract][Full Text] [Related]
31. Dual functional cholinesterase and MAO inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of homoisoflavonoid derivatives.
Wang Y; Sun Y; Guo Y; Wang Z; Huang L; Li X
J Enzyme Inhib Med Chem; 2016; 31(3):389-97. PubMed ID: 25798687
[TBL] [Abstract][Full Text] [Related]
32. New deferiprone derivatives as multi-functional cholinesterase inhibitors: design, synthesis and in vitro evaluation.
Bortolami M; Pandolfi F; De Vita D; Carafa C; Messore A; Di Santo R; Feroci M; Costi R; Chiarotto I; Bagetta D; Alcaro S; Colone M; Stringaro A; Scipione L
Eur J Med Chem; 2020 Jul; 198():112350. PubMed ID: 32380385
[TBL] [Abstract][Full Text] [Related]
33. Multifunctional novel Diallyl disulfide (DADS) derivatives with β-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer's disease.
Manral A; Saini V; Meena P; Tiwari M
Bioorg Med Chem; 2015 Oct; 23(19):6389-403. PubMed ID: 26337018
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and evaluation of quinolinone derivatives containing dithiocarbamate moiety as multifunctional AChE inhibitors for the treatment of Alzheimer's disease.
Fu J; Bao F; Gu M; Liu J; Zhang Z; Ding J; Xie SS; Ding J
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):118-128. PubMed ID: 31694418
[TBL] [Abstract][Full Text] [Related]
35. Development of multifunctional, heterodimeric isoindoline-1,3-dione derivatives as cholinesterase and β-amyloid aggregation inhibitors with neuroprotective properties.
Guzior N; Bajda M; Skrok M; Kurpiewska K; Lewiński K; Brus B; Pišlar A; Kos J; Gobec S; Malawska B
Eur J Med Chem; 2015 Mar; 92():738-49. PubMed ID: 25621991
[TBL] [Abstract][Full Text] [Related]
36. Isoindoline-1,3-dione derivatives targeting cholinesterases: design, synthesis and biological evaluation of potential anti-Alzheimer's agents.
Guzior N; Bajda M; Rakoczy J; Brus B; Gobec S; Malawska B
Bioorg Med Chem; 2015 Apr; 23(7):1629-37. PubMed ID: 25707322
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A
J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459
[TBL] [Abstract][Full Text] [Related]
38. Exploration of multi-target potential of chromen-4-one based compounds in Alzheimer's disease: Design, synthesis and biological evaluations.
Singh M; Kaur M; Singh N; Silakari O
Bioorg Med Chem; 2017 Dec; 25(24):6273-6285. PubMed ID: 29089261
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and evaluation of scutellarein-O-acetamidoalkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Qiang X; Li Y; Xu R; Cao Z; Song Q; Wang T; Zhang X; Liu H; Tan Z; Deng Y
Eur J Med Chem; 2017 Jul; 135():307-323. PubMed ID: 28458136
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and biological evaluation of phthalimide-alkylamine derivatives as balanced multifunctional cholinesterase and monoamine oxidase-B inhibitors for the treatment of Alzheimer's disease.
Sang Z; Wang K; Wang H; Yu L; Wang H; Ma Q; Ye M; Han X; Liu W
Bioorg Med Chem Lett; 2017 Nov; 27(22):5053-5059. PubMed ID: 29033232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
